Objective: To investigate the indicative parameters reflecting the progression of post-thrombotic syndrome (PTS) in patients with a first episode of deep vein thrombosis (DVT). Design and methods: The patients' initial risk factors were assessed at presentation. Venous occlusion, and reflux and reflux parameters were evaluated at 6 months using venous duplex scanning. Near-infrared spectroscopy (NIRS) was also used to measure calf muscle deoxygenated haemoglobin levels at 6 months. Clinical manifestations were categorised using the clinical, etiologic, anatomic and pathophysiologic (CEAP) classification for chronic venous insufficiency (CVI), and the patients were divided into those having no PTS (C 0e3S ,E s ,A s,d,p ,P r,o ) and those having PTS (C 4e6S ,E s ,A s,d,p ,P r,o ). Results: Of the 121 patients evaluated, 25 (21%) developed PTS with a mean follow-up period of 66 months. At initial presentation, ilio-femoral DVT (odds ratio (OR) 3.4, 95% confidence interval (CI) 1.4e8.6) was associated with development of PTS. At 6 months, venous occlusion combined with reflux (OR 4.4, 95% CI 2.9e20.7), peak reflux velocity >29.7 cm s À1 (OR 13.7, 95% CI 4.1e45.7) and mean reflux velocity >8.6 cm s À1 (OR 4.4, 95% CI 1.5e12.9) in the popliteal vein detected by duplex scanning were strong predictors of PTS. NIRS-derived retention index >3.5 was the strongest predictor of PTS at 6 months (OR 67.4, 95% CI 14.3e318.1). Conclusions: Ilio-femoral DVT is associated with the development of PTS at initial presentation. By contrast, occlusion and reflux, high reflux velocity in the popliteal vein and increased NIRS-derived retention index are important time-course predictors of PTS progression. ª
Post-thrombotic syndrome (PTS) is a common late complication of deep vein thrombosis (DVT). Typical symptoms of PTS include pain, heaviness and skin changes ascribed to eczema, pigmentation and ulceration. PTS has been reported to occur in 20e40% of patients who have DVT, and is severe in 5e10%. 1, 2 Recent studies have identified ipsilateral recurrent DVT as a risk factor for PTS. 2, 3 However, most patients with no apparent history of recurrent DVT may also develop severe symptoms of PTS over time. For this reason, it is difficult to reliably predict which patients are likely to develop PTS in the acute phase of DVT.
While most studies have investigated characteristics at the time of initial presentation, follow-up variables may also affect the development of PTS. 4, 5 It is generally believed that PTS develops as a result of venous hypertension due to obstruction, valvular reflux or a combination of the two. In the late phase, the presence of reflux in the femoral vein (FV) and popliteal vein (POPV) is considered to contribute to the development of PTS. In the early phase, however, the role of venous abnormalities in these veins has yet to be determined.
The primary purpose of the present study was to evaluate predictors of PTS, including baseline characteristics at initial presentation as well as follow-up variables at a relative early stage of DVT using non-invasive examination, and to determine the prognostic impact of these parameters on the development of PTS.
Materials and Methods
Consecutive patients with a first episode of acute symptomatic unilateral DVT were potentially eligible for the study. The patients' initial risk factors for DVT, including age, gender, body mass index (BMI), active cancer, congestive heart disease, hormone replacement therapy, immobilisation, inflammatory bowel disease, central venous catheter placement, surgery, previous history of DVT and renal failure were all evaluated. The thrombophilia screening in this study included protein C, protein S, antithrombin III, antiphospholipid antibody and homocysteine level. Patients with arterial insufficiency, identified on the basis of an ankleebrachial pressure index <0.9, those with recurrent DVT, fixed joints, muscle atrophy or weakness and those with limb swelling due to systemic diseases or lymphoedema were excluded from the study. Factor V Leiden and prothrombin G20210A were excluded because all the study patients were Japanese.
The presence of DVT was diagnosed with duplex ultrasound. A colour duplex scanner (LOGIQ 7 PRO: GE Yokogawa Medical Systems, Tokyo, Japan) with a 5e10-MHz transducer was used. Initially, each patient was placed supine in the reverse Trendelenburg position at 15 . Venous duplex scanning was begun at the external iliac vein, common femoral vein and then moved to the FV at the adductor canal. The anterior and posterior tibial veins were also recorded. Afterwards, the patient was placed prone with the knee flexed at 30 , and the residual POPV, peroneal, gastrocnemius and soleal veins were evaluated. The diagnosis of DVT was based on both non-compressibility of the vein on B-mode, and lack of spontaneous flow on colour Doppler imaging. The common and internal iliac veins were not investigated because these veins could not be visualised using duplex ultrasound. The diagnosis of ilio-femoral DVT was established if the proximal veins showed complete occlusion with venous thrombus extending proximally to the external iliac vein. A diagnosis of femoro-popliteal DVT was made if the proximal veins had thrombi without iliac involvement. Finally, a diagnosis of calf vein thrombosis was made if thrombus was detected only in the calf veins.
After initial diagnosis, patients with proximal DVT were treated with intravenous unfractionated heparin for 5e14 days during the acute phase, adjusted to maintain the activated partial thromboplastin time at 1.5e2.5 times the control value, followed by oral warfarin for at least 8 weeks with an international normalised ratio (INR) level of 2e3. Patients with calf vein thrombosis received oral warfarin alone. All patients were encouraged to ambulate, and graduated thigh-high compression stockings were applied immediately after diagnosis. 6 Evaluation of venous reflux was investigated as described previously. 7 At each examination, venous segments were assessed to determine the distribution of thrombosis and whether they were occluded or recanalised. Venous reflux parameters were assessed, especially in the FV and POPV, at the 6-month follow-up point after DVT. For evaluation of the FV, reflux was evaluated at the mid-thigh region, and a pneumatic thigh cuff (Hokanson, Bellevue, WA, USA) was attached to the thigh, inflated to 80 mmHg and then rapidly deflated. For evaluation of the POPV, reflux was evaluated at the popliteal fossa, and a cuff was applied to the calf, inflated to 100 mmHg and then rapidly deflated. The main duplex-derived parameters assessed were diameter (cm), reflux times (RT; s), peak reflux velocity (PRV; cm s À1 ), mean reflux velocity (MRV; cm s À1 ) and total reflux volume (TRV; ml) calculated using the equation: TRV (ml) Z MRV Â Area (r 2 ) Â RT. The vessel cross-sectional area was estimated from the transverse diameter, assuming a circular vessel shape. An RT of >0.5 s was considered to indicate incompetence.
The near-infrared spectroscopy (NIRS) technique allows real-time monitoring of tissue oxygenation, and the details of the examination protocol have been described previously. 8e10 The patient rested supine initially with the leg elevated on a foam block for 5 min. The patients adopted a standing position without putting any weight on the leg being studied, resulting in an increase in deoxygenated haemoglobin (HHb) concentration as the veins filled. The patient was then asked to keep still until a plateau (HHbV) had been reached. Calf venous blood filling index (FI-HHb; mmol(l s) À1 ) was calculated by dividing 90% of the venous blood volume (HHbV90) by the time taken to fill 90% of the venous volume (HHbFT90). Then the patient was asked to perform one tiptoe movement with weightbearing on both legs, which produced an ejected volume (HHbEV), and then return to the initial position, the changes in HHb being observed. The calf venous ejection index (EI-HHb) was calculated as HHbEI Z HHbEV/HHbV. After a new plateau had been reached, the patient was asked to perform 10 tiptoe movements, to achieve venous expulsion (HHbE) and a subsequent retention (HHbR). The venous retention index (RI-HHb) was determined as HHbRI Z HHbR/HHbE. It took approximately 4e5 min to complete the examination and the 10 tiptoe movements were completed within 10 s.
The primary endpoint of this study was the development of PTS. In the cohort study, the follow-up protocol was an outpatient clinic visit at 2 weeks, 1, 3 and 6 months, and every 6 months thereafter. The duration of oral anticoagulation was also recorded. Final clinical manifestations were evaluated more than 36 months after the diagnosis of DVT. The final clinical manifestations of the study patients were categorised according to the CEAP (clinical, etiologic, anatomical and pathophysiologic) classification of reporting standards of venous diseases at their last visit to the outpatient clinic. 11 All the patients had symptoms including aching, pain, tightness, heaviness or muscle cramp to some extent. Therefore, the patients were divided into two groups: those having no PTS (C 0e3S ,E s ,A s,d,p ,P r,o ) and those having PTS (C 4e6S ,E s ,A s,d,p ,P r,o ).
Statistical Analysis
All data were analysed using the Statistical Package for Social Sciences (SPSS) software package (Version 16.0; SPSS Inc., Chicago, IL, USA). Comparisons of numerical data between groups of patients were made using Student's ttest. Chi-squared contingency table analysis was used to evaluate differences between proportions. Statistical significance was defined as p < 0.05. Receiver operating characteristic (ROC) curves were used to assess the predictive power of NIRS-derived parameters. Variables with p < 0.10 were selected as confounding predictors of PTS and were tested using multiple logistic regression analysis.
Results
Overall, 154 consecutive patients were enrolled into the prospective study. Among them, 30 were rejected on the basis of the exclusion criteria and three were lost to followup. The remaining 121 patients were eligible for the study (Fig. 1) . Tables 1 and 2 show the baseline characteristics of the study patients. There was no significant difference in the laterality of DVT. DVT was located in the ilio-femoral segment in 30.6% of patients, the femoro-popliteal segment in 45.4% and the calf in 24%. DVT occurred most commonly after surgery (25 patients, 21%), followed by active cancer (18 patients, 15%) and hormone replacement therapy (13 patients, 11%). At initial assessment, all the patients had symptoms including aching, pain, tightness, heaviness or muscle cramps to some extent. Of these patients, 99 (82%) presented with limb swelling. The final clinical manifestations of the study patients were assessed at a mean of 66.4 months after DVT. Of the 121 patients evaluated, 25 (21%) had PTS. However, the remaining 96 (79%) did not have any post-thrombotic sequelae. Table 3 shows the differences in the baseline characteristics between the patients with and without PTS. The proportion of ilio-femoral DVT was significantly higher in patients who developed PTS than in patients who did not (p < 0.0001). By contrast, patients with calf DVT were significantly less likely to develop PTS (p Z 0.009). There were no significant differences in age, gender, BMI, duration of anticoagulation and risk factors between the two groups. The distribution of venous abnormalities is presented in Table 4 . The proportion of patients with occlusion alone did not differ between the groups. Similarly, the presence of reflux alone did not differ significantly between the groups. By contrast, the proportion of patients with both reflux and obstruction was significantly higher in PTS patients (p < 0.0001). Table 5 shows the duplex-derived venous reflux parameters in the FV and POPV and NIRS-derived parameters at the 6-month follow-up point. There were no significant Healed venous ulcer 3 C 6 Active venous ulcer 2 differences in any of duplex-derived reflux parameters in the FV. On the other hand, PRV in the POPV had significant power to discriminate between the two groups (p Z 0.0008). Similarly, MRV in the POPV was significantly higher in patients with PTS than in those without PTS (p Z 0.030).
With regard to NIRS-derived parameters, there were no significant differences in the values of FI and EI between the groups (Table 5 ). By contrast, the value of RI was significantly higher in patients with PTS than in those without (p < 0.0001).
Using duplex-derived PRV and MRV in the POPV as analytical parameters, a separate ROC curve analysis was conducted, and the most suitable cut-off points with the highest accuracy, minimal false negativity and false positivity for discrimination between the two groups were identified ( Fig. 2(A) ). First, using an optimal cut-off point of 29.7 cm s À1 , PRV showed strong ability to predict the development of PTS with a sensitivity of 62.5%, a specificity of 87%, a positive predictive value of 71.4% and a negative predictive value of 81.6% (area under the curve 0.77, 95% confidence interval (CI) 0.65e0.86, p Z 0.0001). Second, when a MRV cut-off point of 8.6 cm s À1 was used, the clinical discrimination performance was also significant with a sensitivity of 62.5%, a specificity of 69.6%, a positive predictive value of 51.7% and a negative predictive value of 78% (area under the curve 0.68, 95% CI 0.56e0.79, p Z 0.009). Finally, using the NIRS-derived RI for ROC curve analysis, a cut-off value of 3.5 was shown to have the strongest power to discriminate between patients with and without PTS ( Fig. 2(B) ), with a sensitivity of 92%, a specificity of 85.4%, a positive predictive value of 62.1% and a negative predictive value of 97.6% (area under the curve 0.95, 95% CI 0.89e0.98, p Z 0.0001). The confounding predictors of PTS were finally tested using multivariate analysis (Table 6) . At initial presentation, initial thrombus involvement of the ilio-femoral segment was significantly associated with severe symptoms of PTS (odds ratio (OR) 3.44, 95% CI 1.38e8.58, p Z 0.008). By contrast, calf DVT was independently associated with a lower prevalence of PTS (OR 0.10, 95% CI 0.01e0.79, p Z 0.028).
At the 6-month point, patients lacking venous abnormalities were significantly unlikely to develop PTS symptoms (OR 0.07, 95% CI 0.01e0.54, p Z 0.011). By contrast, venous occlusion combined with reflux was independently predictive of PTS (OR 4.40, 95% CI 2.87e20.72, p < 0.0001). PRV > 29.7 cm s À1 in the POPV was the strongest duplexderived predictor of PTS (OR 13.67, 95% CI 4.09e45.65, p < 0.0001), followed by MRV > 8.6 cm s À1 in the POPV (OR 4.36, 95% CI 1.53e12.89, p Z 0.006). RI > 3.5 detected by NIRS was the strongest predictor of PTS at the 6-month follow-up point (OR 67.36, 95% CI 14.26e318.06, p < 0.0001).
Discussion
This study confirmed the possible predictors of disease progression in patients with a first episode of DVT. Our main findings were that (1) the involvement of the ilio-femoral segment was significantly associated with severe symptoms of PTS at initial presentation. At the 6-month follow-up point, we found that (2) venous occlusion combined with reflux was independently predictive of PTS, (3) PRV > 29.7 cm s À1 in the POPV was the strongest predictor of PTS (OR 13.67, 95% CI 4.09e45.65, p < 0.0001) followed by MRV > 8.6 cm s À1 in the POPV (OR 4.36, 95% CI 1.53e12.89, p Z 0.006) and (4) an optimal cut-off point of 3.5 for NIRSderived RI showed the strongest ability to predict the deterioration of PTS symptoms (OR 67.36, 95% CI 14.26e318.06, p < 0.0001).
Although many risk factors for DVT have been identified to date, the only risk factors identified previously for PTS have been ipsilateral recurrence of DVT 2,3 and increased BMI. 12e15 Increased age has also been proven to be associated with a higher risk of DVT, but appears to have no definite association with PTS. 16e18 The presence of factor V Leiden or prothrombin gene mutation is reportedly an independent predictor of a lower risk of PTS. 18 The initial distribution of DVT may affect the clinical progression of the disease. The risk of PTS is reportedly higher in patients with proximal rather than distal DVT. 13 Furthermore, patients with acute ilio-femoral DVT develop the most severe post-thrombotic sequelae. 19 A recent prospective, multicentre study of predictors of PTS in North America demonstrated that patients with more severe post-thrombotic manifestations 1 month after DVT had a poorer long-term outcome over 2 years, suggesting that the persistence of venous symptoms and signs at 1 month may be attributable to residual venous thrombosis, especially in the ilio-femoral venous segment. 20 In the present study, ilio-femoral DVT was only predictive of PTS.
In the late phase, reflux in the proximal deep veins contributed significantly to the development of PTS. 21 However, the association between the progression of PTS and the role of venous abnormalities in the early phase has yet to be determined. Previous studies showed that valve incompetence developed most frequently in segments that had been initially affected by thrombi, and that less valve damage was evident in the calf vein segment. The incompetence in segments without initial documented thrombosis may be the result of unnoticed thrombus propagation. The development of reflux in a specific segment will be due, in most cases, to the damage caused to the valve by Figure 2 Ability of duplex-derived peak reflux velocity (PRV), mean reflux velocity (MRV) in the popliteal vein, and nearinfrared spectroscopy-derived venous retention index (RI) to predict PTS. A. The blue line denotes the PRV (area under the curve 0.77, 95% confidence interval 0.65e0.86, P Z 0.0001) with a sensitivity of 62.5%, a specificity of 87%, a positive predictive value of 71.4%, and a negative predictive value of 81.6%. The green line denotes the MRV with a sensitivity of 62.5%, a specificity of 69.6%, a positive predictive value of 51.7%, and a negative predictive value of 78% (area under the curve 0.68, 95% confidence interval 0.56e0.79, p Z 0.009). B. An optimal cut-off point of 3.5 for RI showed the strongest ability to predict the development of PTS, with a sensitivity of 92%, a specificity of 85.4%, a positive predictive value of 62.1%, and a negative predictive value of 97.6% (area under the curve 0.95, 95% confidence interval 0.89e0.98, p Z 0.0001).
the thrombotic process. 22, 23 These findings are in accord with those of the present study.
In a previous study, we found that reflux in the proximal deep veins was an important contributor to severe symptoms of PTS at the 2-year follow-up point. 24 Furthermore, we showed that the presence of reflux as reflected by an elevated PRV in the POPV (>25.4 cm s À1 ) and FV (>24.5 cm s À1 ) was an independent predictor of PTS at 2 years after DVT. 22 In the present study, however, the presence of reflux alone was not predictive of PTS at 6 months after DVT. Despite the fact that PRV and MRV in the FV were unlikely to predict the development of PTS, these parameters in the POPV were predictive of PTS at 6 months. The optimal cut-off points for PRV and MRV in the POPV were relatively higher, with a lower OR, in the present study than those at 2 years in our previous study, suggesting poorer luminal recanalisation in the proximal veins at the 6month follow-up point.
Among the parameters evaluated in this study, NIRSderived RI > 3.5 was the strongest predictor of deterioration of PTS symptoms. Our previous study of the use of NIRSderived parameters for clinical prediction of PTS found that (1) FI and RI measured by NIRS appeared to be promising for prediction of PTS after DVT, (2) EI measured by NIRS was significantly more reduced in patients with proximal DVT than in those with calf DVT, (3) RI was significantly more increased in patients with ilio-femoral DVT than in those with calf DVT and (4) an optimal cut-off point of 2.9 for HHbRI had a strong capability for predicting PTS. 8 These factors might reflect diminished calf muscle pump function as a result of pre-existing venous obstruction, venous reflux or a combination of the two, leading to higher ambulatory venous pressure and development of PTS.
Our present study had some limitations. First, it had a limited sample size, which may have introduced a potential for type II statistical error. Further analysis of the risk of PTS was difficult to perform (e.g., comparison by decade of age and by BMI according to the criteria of the World Health Organization). A large sample size will, therefore, be required to confirm the relationship between the investigated parameters and clinical outcome. Second, we did not investigate the effect of reflux in the superficial venous system. Labropoulos et al. reported that 47% of patients with symptomatic PTS had both superficial and deep venous insufficiency. 25 However, superficial vein incompetence will appear over time, and our previous study did not confirm any significant role of superficial venous reflux for predicting the development of PTS at the 2-year follow-up point. 21 Third, we excluded patients with recurrent DVT, even though it is recognised as a high-risk factor for PTS. Because duplex-and NIRS-derived parameters will change after the development of recurrent DVT, the relationship between the initial distribution of DVT and these parameters might have been concealed. Nevertheless, our study clearly demonstrated the significance of duplex-and NIRS-derived parameters at the 6-month follow-up point as prognostic variables in patients with a first episode of DVT. Finally, despite the considerable incidence of PTS encountered in clinical practice, an objective assessment of its severity is still difficult. Airplethysmography (APG) could be used to evaluate ambulatory venous function, but APG parameters do not correctly reflect data obtained in the presence of proximal occlusion. By contrast, venous occlusion does not affect NIRS-derived parameters. We previously tried to correlate APG-derived parameters with NIRS-derived ones, but found there were no significant relationships between venous filling index and FI-HHb, ejection fraction and EI-HHb or residual volume fraction and RI-HHb (unpublished data). 9 In conclusion, we detected symptoms of PTS in 20.7% of patients with a first episode of DVT. The ilio-femoral DVT at initial presentation was associated with the development of PTS. By contrast, occlusion and reflux in the proximal deep vein, duplex-derived high PRV (>29.7 cm s À1 ) and high MRV (>8.6 cm s À1 ) in the POPV and increased NIRS-derived RI (>3.5) were important time-course predictors of the deterioration of PTS symptoms. These results appear to reflect the possibility that a high reflux velocity in the POPV and increased calf muscle deoxygenation during exercise are suggestive of future venous malfunction in patients with a first episode of DVT.
